Article
Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
2018-12-05
Abstract excerpt
Liquid biopsy, based on the circulating tumor cells (CTCs) and cell-free nucleic acids has potential applications at multiple points throughout the natural course of cancer, from diagnosis to follow-up. The advantages of doing ctDNA assessment vs. tissue-based genomic profile are the minimal procedural risk, the possibility to serial testing in order to monitor disease-relapse and response to therapy over time and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 01f43641-91a5-5054-a6de-53ee93753d34
- DOI
- 10.20944/preprints201812.0066.v1